What is Chemisys?
Chemisys Laboratory operates as a premier national medical facility, distinguishing itself through a multi-disciplinary approach to genetics testing, toxicology, and the emerging field of micro-plastic and nano-plastic analysis. By bridging the gap between environmental science and clinical diagnostics, the firm provides essential data-driven insights that empower healthcare providers and patients alike. Its commitment to identifying environmental contaminants and their subsequent physiological impacts places Chemisys at the forefront of modern preventative medicine and environmental health research. The laboratory serves as a vital node in the healthcare ecosystem, translating complex molecular data into actionable health outcomes.
How much funding has Chemisys raised?
Chemisys has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Chemisys
PPP
Public-Private Partnership
What's next for Chemisys?
With the infusion of this latest capital, Chemisys is poised to accelerate its operational capacity and deepen its research capabilities in toxicology. The strategic focus will likely shift toward scaling high-throughput testing platforms and enhancing the sensitivity of its nano-plastic detection methodologies. As the regulatory landscape surrounding environmental health continues to evolve, the company is strategically aligned to capture increased demand for specialized diagnostic services. Future growth initiatives will likely prioritize the integration of advanced analytical technologies to maintain its competitive edge in the national laboratory market, ensuring that the firm remains a cornerstone for both clinical and environmental diagnostic excellence.
See full Chemisys company page
